To estimate the economic costs and benefits of routine childhood vaccination against varicella infection.
Decision-analytic model of the incidence and costs of chickenpox in children assumed to receive varicella vaccine at age 15 months in conjunction with the measles-mumps-rubella vaccine, or not to be vaccinated against varicella.
Hypothetical cohort of 100,000 children.
Costs of vaccination, cumulative incidence of chickenpox to age 25 years, and related disease costs, including medical treatment and work loss.
Vaccination of 100,000 children against varicella at age 15 months would cost $4,812,000.
Mots-clés Pascal : Varicelle, Virose, Infection, Vaccin, Vaccination, Enfant, Homme, Immunoprophylaxie, Etude statistique, Evaluation, Coût, Economie santé, Massachusetts, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Varicella, Viral disease, Infection, Vaccine, Vaccination, Child, Human, Immunoprophylaxis, Statistical study, Evaluation, Costs, Health economy, Massachusetts, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0535742
Code Inist : 002B05C02A. Création : 199501.